The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $41.32

Today's change+0.22 +0.54%
Updated May 2 3:35 PM EDT. Delayed by at least 15 minutes.
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $41.32

Today's change+0.22 +0.54%
Updated May 2 3:35 PM EDT. Delayed by at least 15 minutes.

Sanofi SA crosses above 50-day moving average

Sanofi SA is up today by (U.S.)$0.22 or 0.54% to (U.S.)$41.32 and crossing above its 50-day moving average. Over the last five days, shares have lost 6.77% and are down 3.12% for the last year to date. This security has underperformed the S&P 500 by 18.10% during the last year.

Key company metrics

  • Open(U.S.) $41.55
  • Previous close(U.S.) $41.10
  • High(U.S.) $41.70
  • Low(U.S.) $41.04
  • Bid / Ask(U.S.) $41.31 / (U.S.) $41.32
  • YTD % change-3.12%
  • Volume3,000,629
  • Average volume (10-day)1,609,254
  • Average volume (1-month)2,431,456
  • Average volume (3-month)2,035,658
  • 52-week range(U.S.) $37.63 to (U.S.) $54.98
  • Beta0.98
  • Trailing P/E21.58×
  • P/E 1 year forward13.13×
  • Forward PEG1.80×
  • Indicated annual dividend(U.S.) $1.63
  • Dividend yield3.95%
  • Trailing EPS(U.S.) $1.92
Updated May 2 3:35 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.01%

Based on its net profit margin of 13.01%, Sanofi SA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.66%Sector:Industry:

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue34,8619,68018,3518,890
Total other revenue--------
Total revenue34,8619,68018,3518,890
Gross profit23,9426,68212,6276,104
Total cost of revenue10,9192,9985,7242,786
Total operating expense29,2877,72514,9577,487
Selling / general / administrative--2,4615,0862,438
Research & development5,0821,3552,4891,199
Depreciation / amortization2,1375981,229618
Interest expense (income), net operating--------
Unusual expense (income)1,612267413380
Other operating expenses, total155461666
Operating income5,5741,9553,3941,403
Interest income (expense), net non-operating-246---132--
Gain (loss) on sale of assets--------
Other--------
Income before tax5,2431,8503,1891,306
Income after tax4,5341,5782,4501,086
Income tax, total709272739220
Net income4,2871,6282,3251,023
Total adjustments to net income--------
Net income before extra. items4,4111,6282,3251,023
Minority interest-101-23-59-32
Equity in affiliates-2273-66-31
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4,4111,6282,3251,023
Inc. avail. to common incl. extra. items4,2871,6282,3251,023
Diluted net income4,2921,6282,3271,023
Dilution adjustment5--2--
Diluted weighted average shares1,3211,3131,3221,308
Diluted EPS excluding extraordinary itemsvalue per share3.341.241.760.78
Dividends per sharevalue per share2.930.000.000.00
Diluted normalized EPSvalue per share4.401.412.001.02